Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
TORONTO, March 28, 2026 (GLOBE NEWSWIRE) -- (TSX: SPFD) Mulvihill Enhanced Split Preferred Share ETF (the “Fund”) (formerly Mulvihill U.S. Health Care Enhanced Yield ETF) announces results of...
-
AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session Across the COAST 1, COAST 2, and SHORE phase 3 studies, amlitelimab, dosed...
-
Featured presentation highlights positive BroADen Phase 1b atopic dermatitis trial results supporting KT-621’s compelling oral profile Parallel Phase 2b trials, BROADEN2 in atopic dermatitis and...
-
Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at 2026 AAD
-
Rocket Lab successfully launched a pair of satellites for the European Space Agency (ESA) to test new navigation systems in low Earth orbit.
-
NEW YORK, March 28, 2026 (GLOBE NEWSWIRE) -- Cointelegraph Research has released a new analysis examining how the United Nations Development Programme (UNDP) is testing blockchain technology to...
-
New data analyses from the Company’s varoglutamstat Phase 2 program were presented at the World Congress of Nephrology.
-
TheraWolf PainBalm and NeuroBalm claims evaluated: ingredient disclosures, topical relief expectations, pricing, and what buyers overlook in 2026
-
(All dollar amounts are expressed in Canadian dollars, unless stated otherwise) HIGHLIGHTS Q4 2025 (at December 31, 2025) Financial: ~$422.3 million in cash and cash equivalents; sold 3,970...
-
Phoenix, AZ, March 27, 2026 (GLOBE NEWSWIRE) -- MidPoint Capital Partners, LLC announced the launch of a $500 million private real estate lending fund, MidPoint Capital, LLC, designed to provide...